Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0900
-0.0085 (-8.63%)
Oct 8, 2025, 3:59 PM EDT
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $39.36 million as of October 8, 2025. Its market cap has increased by 319.94% in one year.
Market Cap
39.36M
Enterprise Value
51.91M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 39.36M, an increase of 330.44%. That is a compound annual growth rate of 25.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 43.12M | 202.49% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | 19.26M | 34.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 683.67M |
| Glass House Brands | 645.74M |
| Veradigm | 528.17M |
| Northwest Biotherapeutics | 379.57M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 274.14M |
| Silence Therapeutics | 242.78M |